| Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats DR Kalaria, G Sharma, V Beniwal, MNV Ravi Kumar Pharmaceutical research 26, 492-501, 2009 | 272 | 2009 |
| Erbium: YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies J Yu, DR Kalaria, YN Kalia Journal of controlled release 156 (1), 53-59, 2011 | 79 | 2011 |
| Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A PA Patel, SC Patil, DR Kalaria, YN Kalia, VB Patravale International journal of pharmaceutics 446 (1-2), 16-23, 2013 | 73 | 2013 |
| Non-invasive iontophoretic delivery of peptides and proteins across the skin T Gratieri, D Kalaria, YN Kalia Expert opinion on drug delivery 8 (5), 645-663, 2011 | 68 | 2011 |
| An industrial approach towards solid dosage development for first-in-human studies: Application of predictive science and lean principles DR Kalaria, K Parker, GK Reynolds, J Laru Drug Discovery Today 25 (3), 505-518, 2020 | 29 | 2020 |
| Controlled iontophoretic delivery of pramipexole: Electrotransport kinetics in vitro and in vivo DR Kalaria, P Patel, V Merino, VB Patravale, YN Kalia European Journal of Pharmaceutics and Biopharmaceutics 88 (1), 56-63, 2014 | 28 | 2014 |
| Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: transdermal polypharmacy to treat Parkinson’s disease DR Kalaria, M Singhal, V Patravale, V Merino, YN Kalia European Journal Of Pharmaceutics And Biopharmaceutics 127, 204-212, 2018 | 26 | 2018 |
| Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro DR Kalaria, P Patel, V Patravale, YN Kalia International journal of pharmaceutics 438 (1-2), 202-208, 2012 | 25 | 2012 |
| Controlled Iontophoretic Transport of Huperzine A across Skin in Vitro and in Vivo: Effect of Delivery Conditions and Comparison of Pharmacokinetic Models DR Kalaria, P Patel, V Merino, VB Patravale, YN Kalia Molecular pharmaceutics 10 (11), 4322-4329, 2013 | 19 | 2013 |
| Microemulsion-based gel for the transdermal delivery of rasagiline mesylate: In vitro and in vivo assessment for Parkinson’s therapy P Patel, A Pol, D Kalaria, AA Date, Y Kalia, V Patravale European Journal of Pharmaceutics and Biopharmaceutics 165, 66-74, 2021 | 18 | 2021 |
| Colloidal soft nanocarrier for transdermal delivery of dopamine agonist: Ex vivo and in vivo evaluation P Patel, A Pol, S More, DR Kalaria, YN Kalia, VB Patravale Journal of biomedical nanotechnology 10 (11), 3291-3303, 2014 | 14 | 2014 |
| Clinical applications of transdermal iontophoresis DR Kalaria, S Dubey, YN Kalia Topical and Transdermal Drug Delivery and Development, 67-83, 2012 | 14 | 2012 |
| Design of biodegradable nanoparticles for oral delivery of doxorubicin DR Kalaria, G Sharma, V Beniwal, MNVR Kumar vivo, 2009 | 12 | 2009 |
| Development and validation of a HPAE‐PAD method for the quantification of CGP69669A, a sialyl Lewisx mimetic, in skin permeation studies T Gratieri, B Wagner, D Kalaria, B Ernst, YN Kalia Biomedical chromatography 26 (4), 507-511, 2012 | 6 | 2012 |
| Effect of continuous and multi-phasic current profiles on the iontophoretic transport of pramipexole, rasagiline and huperzine A: Depicting temporal variation and … M Singhal, C Serna, D Kalaria, YN Kalia International Journal of Pharmaceutics 599, 120445, 2021 | 4 | 2021 |
| Cutaneous iontophoretic delivery of CGP69669A, a sialyl Lewisx mimetic, in vitro T Gratieri, B Wagner, D Kalaria, B Ernst, YN Kalia Experimental dermatology 21 (3), 226-228, 2012 | 4 | 2012 |
| Transdermal iontophoresis for the controlled delivery of therapeutic agents to treat neurodegenerative diseases D Kalaria | 2 | 2012 |
| Iontophoretic Delivery of Glycomimetics-A New Approach for the Treatment of Inflammatory Skin Diseases T Gratieri, B Wagner, D Kalaria, B Ernst, YN Kalia | 1 | 2013 |
| Corrigendum to" An industrial approach towards solid dosage development for first-in-human studies: Application of predictive science and lean principles"[Drug Discov. Today 25 … DR Kalaria, K Parker, GK Reynolds, J Laru Drug Discovery Today 26 (8), 2076-2076, 2020 | | 2020 |
| Influence of Formulation and Tablet Shape on Tablet Integrity: Identification of Novel Methodologies for Characterisation M Singhal, J Sorjonen, H Wikström, P Upadhyay, D Kalaria, F Alhusban, ... Available at SSRN 4685754, 0 | | |
